REGULATION OF FOCAL ADHESION TURNOVER BY ERBB RECEPTOR SIGNALING AND PRECLINICAL IMPLICATIONS FOR ERBB-2+INVASIVE BREAST CANCER MODELS

被引：0
|
作者：
Alaoui-Jamali, Moulay [1 ]
机构：
[1] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst, Segall Comprehens Canc Ctr,Dept Med & Oncol, Montreal, PQ H3T 1E2, Canada
来源：
ANTICANCER RESEARCH | 2008年 / 28卷 / 5C期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8
引用
收藏
页码：3187 / 3188
页数：2
相关论文
共 50 条
  • [41] Insights from transgenic mouse models of ERBB2-induced breast cancer
    Josie Ursini-Siegel
    Babette Schade
    Robert D. Cardiff
    William J. Muller
    Nature Reviews Cancer, 2007, 7 : 389 - 397
  • [42] Valproic acid reverses trastuzumab resistance in erbB2-positive breast cancer cells via downregulation of ErbB2/ErbB3 signaling through induction of ErbB family members-targeting miRNAs
    Lin, Tingting
    Ren, Qun
    Zuo, Weimin
    Lin, Rong
    Zhao, Hu
    Wang, Ping
    Tan, Jianming
    Lyu, Hui
    Liu, Bolin
    Wang, Shuiliang
    CANCER RESEARCH, 2018, 78 (13)
  • [43] Quantitation of EGFR and c-erbB-2 expression in preinvasive compared to invasive breast cancer
    Chong, D
    Cooke, TG
    Reeves, JR
    George, WD
    Mallon, EA
    Ozanne, B
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S203 - S203
  • [44] Management of ErbB2-positive Breast Cancer: Insights from Preclinical and Clinical Studies with Lapatinib
    Vogel, Charles
    Chan, Arlene
    Gril, Brunilde
    Kim, Sung-Bae
    Kurebayashi, Junichi
    Liu, Li
    Lu, Yen-Shen
    Moon, Hanlim
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (11) : 999 - 1013
  • [45] Disruption of Laminin-Integrin-CD151-Focal Adhesion Kinase Axis Sensitizes Breast Cancer Cells to ErbB2 Antagonists
    Yang, Xiuwei H.
    Flores, Ludmila M.
    Li, Qinglin
    Zhou, Pengcheng
    Xu, Fenghui
    Krop, Ian E.
    Hemler, Martin E.
    CANCER RESEARCH, 2010, 70 (06) : 2256 - 2263
  • [46] Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast
    Lee, Ahwon
    Park, Woo Chan
    Yim, Hyeon Woo
    Lee, Myung Ah
    Park, Gyeongsin
    Lee, Kyo Young
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (09) : 708 - 714
  • [47] NM23 AND C-ERBB-2 EXPRESSION IN INVASIVE BREAST-CANCER
    NOGUCHI, M
    EARASHI, M
    OHNISHI, I
    KINOSHITA, K
    THOMAS, M
    FUSIDA, S
    MIYAZAKI, I
    MIZUKAMI, Y
    ONCOLOGY REPORTS, 1994, 1 (03) : 523 - 528
  • [48] Genomic alterations in ERBB2 define a subset of pleomorphic invasive lobular breast cancer
    Hirshfield, Kim M.
    Sanders, Renee
    Feld, Heather K.
    Barnard, Nicola
    Liang, Li
    Zhong, Hua
    Bhanot, Gyan
    Sahota, Amrik S.
    Brooks, Andrew
    Rodriguez-Rodriguez, Lorna
    Ganesan, Shridar
    CANCER RESEARCH, 2015, 75
  • [49] erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line
    Ethier, SP
    Kokeny, KE
    Ridings, JW
    Dilts, CA
    CANCER RESEARCH, 1996, 56 (04) : 899 - 907
  • [50] ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells
    Choi, Byung-Kwon
    Fan, Xuejun
    Deng, Hui
    Zhang, Ningyan
    An, Zhiqiang
    CANCER MEDICINE, 2012, 1 (01): : 28 - 38
12345